Position in LH
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$1,006,940
+$549,586 QoQ
Shares Held
3,774
+107.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Brooklyn Investment Group holds $19,927,193 across 17 Diagnostics & Research names. LH ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
11,289 | $5,548,882 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
4,901 | $2,753,822 | |
| 3 | DHR |
Danaher Corp /De/
|
12,121 | $2,298,141 | |
| 4 | A |
Agilent Technologies, Inc.
|
11,896 | $1,355,906 | |
| 5 | ILMN |
Illumina, Inc.
|
10,736 | $1,323,319 | |
| 6 | LH |
Labcorp Holdings Inc.
This page
|
3,774 | $1,006,940 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
5,569 | $949,737 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
587 | $740,324 |
All Filings in LH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,006,940 | 3,774 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $457,354 | 1,823 | Shares | Defined | 2026-02-12 | |
| 2025-03-31 | $260,203 | 1,118 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $149,287 | 651 | Shares | Defined | 2025-01-15 | |
| 2024-09-30 | $128,947 | 577 | Shares | Defined | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||